Hyundai Hope On Wheels (HHOW)

No applicants // Limit: 1 // Tickets Available: 1

T. Kalin ( Phoenix Children’s Research Institute -Translational Research) Subaward 

Hyundai Hope On Wheels® [“HHOW”] is a 501(c)(3) non-profit organization that joined the fight against childhood cancer in 1998. The organization funds life-saving research and creates awareness for childhood cancer. Since its inception, HHOW has donated more than $225 million to fund pediatric cancer research. 

In 2024, the following categories of research grants for pediatric cancer are available per this RFP: 

• Hope Scholar Grant: $400,000 (two-year award), please see pages 4-5 for details. 

• Young Investigator Grant: $250,000 (two-year award), please see page 6 for details. 

Eligibility to apply for a Hope Scholar or Young Investigator Grant is limited to Children’s Oncology Group (“COG”) member institutions in the U.S. Each eligible institution may submit up to one application per grant category. Applicants will be notified by March 15, 2024, about grant awardees. If selected, the first funding installment is planned for release on December 31, 2024. Approved research projects may begin upon receipt of the initial grant award disbursement. If selected, material conditions for the institution that receives a grant are to agree to all terms and conditions of the grant agreement, and to agree to host a Hyundai Hope On Wheels handprint ceremony at its location or virtually during August or September of 2024. 

No applicants // Limit: 1 // Tickets Available: 1

Hyundai Hope On Wheels® [“HHOW”] is a 501(c)(3) non-profit organization that joined the fight against childhood cancer in 1998. The organization funds life-saving research and creates awareness for childhood cancer. Since its inception, HHOW has donated more than $225 million to fund pediatric cancer research. 

In 2024, the following categories of research grants for pediatric cancer are available per this RFP: 

• Hope Scholar Grant: $400,000 (two-year award), please see pages 4-5 for details. 

• Young Investigator Grant: $250,000 (two-year award), please see page 6 for details. 

Eligibility to apply for a Hope Scholar or Young Investigator Grant is limited to Children’s Oncology Group (“COG”) member institutions in the U.S. Each eligible institution may submit up to one application per grant category. Applicants will be notified by March 15, 2024, about grant awardees. If selected, the first funding installment is planned for release on December 31, 2024. Approved research projects may begin upon receipt of the initial grant award disbursement. If selected, material conditions for the institution that receives a grant are to agree to all terms and conditions of the grant agreement, and to agree to host a Hyundai Hope On Wheels handprint ceremony at its location or virtually during August or September of 2024. 

No applicants // Limit: 1 // Tickets Available: 1 

The intent of the HHOW pediatric cancer research grants is to provide funding for principal investigators (herein referred to as “PI”), whose research projects are likely to have a significant impact on improving the understanding of the biology of childhood cancer and/or developing novel diagnostic, prognostic, and therapeutic approaches for pediatric malignancies. The grants are awarded to the institution for the benefit of the research of the approved projects. Projects eligible to be funded by this program will be those that pursue innovative research that is translational in nature, that is, has the potential to impact childhood cancer diagnosis and treatment. Proposals requesting support for clinical trials are not eligible for consideration.

Funding for the Grants is awarded to the applying institution (herein referred to as the applicant) for the purpose of supporting the PI and the research specified in the proposal. Submitting PIs must include a letter of support from the division chief of pediatric oncology at the applicant institution, and concurrence of the development office. With the submission of the Grant application(s), the PI(s) confirm(s) that each is authorized by the officers of the institution to submit the application and the institution agrees to abide by all terms and conditions of the grant.

The funds of awarded grants may not be transferred to a different institution under any circumstance, should the designated PI leave the institution for any reason.However, the institution may nominate a new qualified candidate to serve as the PI, subject to the new candidate meeting all guidelines and with no substantive changes to the approved project.

2023 HYUNDAI YOUNG INVESTIGATOR GRANT
The Hyundai Young Investigator’s Grant is a $200,000 grant, which will be provided as $100,000 per year grant for years 1 and 2.
Eligible Criteria for Young Investigator:

1. PI must be an MD or MD/PhD who is currently in his/her 3rd or 4th year of an accredited pediatric hematology-oncology fellowship training program and involved in pediatric cancer research; or
2. Must be a pediatric oncologist/MD, or MD/PhD in his/her initial academic appointment, within 6 years from completion of fellowship training, and involved in pediatric cancer research.
3. A PhD is not eligible to be a PI, for the purposes of the award, but may participate as a member of a research team.

Research proposals will be evaluated based on:

1. Relevance to pediatric cancer
2. Quality of science
3. Innovation
4. Potential for success
5. Potential impact on the field
6. Quality of applicant
7. Quality of institutional environment
8. Demonstrated need for funding

• Only ONE proposal in each category (i.e. one Young Investigator and one Scholar Hope may be submitted from any individual Applicant), for a total of TWO per institution.
• A PI may apply in either category, but not both. An applying PI may not have two HHOW grants at the same time. If the PI is a current HHOW grant awardee, they may not apply for a second HHOW grant award until the second year of their current award.
• Grant funds may be used to support bench or translational research and must have a direct relevance to pediatric cancer. 
• Less than 10% of funds can be used for indirect costs and no funds can be used for fringe benefits through the Scholar Hope or Young Investigator Grants.
• Applicants may use funds in conjunction with another award on the same topic. However, the difference has to be clearly identified in the budget.
• If Applicant has submitted multiple applications to other foundations or granting agencies, for funding the same project  concurrently, HHOW must be notified in the written application (Section VII below)
• The PI for either the Young Investigator or Hope Scholar award may not have more than 1 RO1 or RO1-equivalent at the time of application. K awards or equivalent are permitted for Young Investigator and Scholar PIs.

E. Katsanis ( College of Medicine - Pediatric Hematology / Oncology)

UA may submit one proposal. 

The intent of the HHOW pediatric cancer research grants is to provide funding for principal investigators (herein referred to as “PI”), whose research projects are likely to have a significant impact on improving the understanding of the biology of childhood cancer and/or developing novel diagnostic, prognostic, and therapeutic approaches for pediatric malignancies. The grants are awarded to the institution for the benefit of the research of the approved projects. Projects eligible to be funded by this program will be those that pursue innovative research that is translational in nature, that is, has the potential to impact childhood cancer diagnosis and treatment. Proposals requesting support for clinical trials are not eligible for consideration.

Funding for the Grants is awarded to the applying institution (herein referred to as the applicant) for the purpose of supporting the PI and the research specified in the proposal. Submitting PIs must include a letter of support from the division chief of pediatric oncology at the applicant institution, and concurrence of the development office. With the submission of the Grant application(s), the PI(s) confirm(s) that each is authorized by the officers of the institution to submit the application and the institution agrees to abide by all terms and conditions of the grant.

The funds of awarded grants may not be transferred to a different institution under any circumstance, should the designated PI leave the institution for any reason. However, the institution may nominate a new qualified candidate to serve as the PI, subject to the new candidate meeting all guidelines and with no substantive changes to the approved project.
 

2023 SCHOLAR HOPE GRANT

The Scholar Hope Grant is a $300,000 award (paid $150,000 per year), which may be used for up to two years. Approved funding may be used only for the purposes expressly set forth in the applicant’s proposal and specifically performed under the auspices of the PI identified in the proposal.

Applicant eligibility for Scholar Hope Grant:

1. PI must be an MD or MD/PhD whose research is focused on pediatric oncology.
2. A PhD is not eligible to be a PI, for the purposes of the award, but may participate as a member of a research team.
3. PIs must have completed their fellowship sub-specialty training at the time of the award.
4. Applicant may have no more than 1 R01 or R01-equivalent grant, at the time of application.
5. Applicants must be based in and research is focused on projects within the U.S. market.
6. Clinical research studies or medical trials are not eligible for consideration.
7. Applicant may not have concurrent HHOW funding, but may apply during the second year of funding for a second HHOW grant (i.e. consecutive funding).

Research proposals will be evaluated based on:

1. Relevance to pediatric cancer
2. Quality of science
3. Innovation
4. Potential for success
5. Potential impact on the field
6. Quality of applicant
7. Quality of institutional environment
8. Demonstrated need for funding

• Only ONE proposal in each category (i.e. one Young Investigator and one Scholar Hope may be submitted from any individual Applicant), for a total of TWO per institution.
• A PI may apply in either category, but not both. An applying PI may not have two HHOW grants at the same time. If the PI is a current HHOW grant awardee, they may not apply for a second HHOW grant award until the second year of their current award.
• Grant funds may be used to support bench or translational research and must have a direct relevance to pediatric cancer. 
• Less than 10% of funds can be used for indirect costs and no funds can be used for fringe benefits through the Scholar Hope or Young Investigator Grants.
• Applicants may use funds in conjunction with another award on the same topic. However, the difference has to be clearly identified in the budget.
• If Applicant has submitted multiple applications to other foundations or granting agencies, for funding the same project  concurrently, HHOW must be notified in the written application (Section VII below)
• The PI for either the Young Investigator or Hope Scholar award may not have more than 1 RO1 or RO1-equivalent at the time of application. K awards or equivalent are permitted for Young Investigator and Scholar PIs.